| Inherited causes of clonal haematopoiesis in 97,691 whole genomes AG Bick, JS Weinstock, SK Nandakumar, CP Fulco, EL Bao, SM Zekavat, ... Nature 586 (7831), 763-768, 2020 | 459 | 2020 |
| PON-P2: prediction method for fast and reliable identification of harmful variants A Niroula, S Urolagin, M Vihinen PloS one 10 (2), e0117380, 2015 | 225 | 2015 |
| Distinction of lymphoid and myeloid clonal hematopoiesis A Niroula, A Sekar, MA Murakami, M Trinder, M Agrawal, WJ Wong, ... Nature medicine 27 (11), 1921-1927, 2021 | 157 | 2021 |
| Variation interpretation predictors: principles, types, performance, and choice A Niroula, M Vihinen Human mutation 37 (6), 579-597, 2016 | 136 | 2016 |
| Association of clonal hematopoiesis with chronic obstructive pulmonary disease PG Miller, D Qiao, J Rojas-Quintero, MC Honigberg, AS Sperling, ... Blood, The Journal of the American Society of Hematology 139 (3), 357-368, 2022 | 131 | 2022 |
| Association of clonal hematopoiesis with incident heart failure B Yu, MB Roberts, LM Raffield, SM Zekavat, NQH Nguyen, ML Biggs, ... Journal of the American College of Cardiology 78 (1), 42-52, 2021 | 113 | 2021 |
| Clonal hematopoiesis is associated with higher risk of stroke R Bhattacharya, SM Zekavat, J Haessler, M Fornage, L Raffield, ... Stroke 53 (3), 788-797, 2022 | 107 | 2022 |
| Premature menopause, clonal hematopoiesis, and coronary artery disease in postmenopausal women MC Honigberg, SM Zekavat, A Niroula, GK Griffin, AG Bick, JP Pirruccello, ... Circulation 143 (5), 410-423, 2021 | 103 | 2021 |
| Prediction of risk for myeloid malignancy in clonal hematopoiesis LD Weeks, A Niroula, D Neuberg, W Wong, RC Lindsley, MR Luskin, ... NEJM evidence 2 (5), EVIDoa2200310, 2023 | 96 | 2023 |
| How good are pathogenicity predictors in detecting benign variants? A Niroula, M Vihinen PLoS computational biology 15 (2), e1006481, 2019 | 95 | 2019 |
| Dnmt3a-mutated clonal hematopoiesis promotes osteoporosis PG Kim, A Niroula, V Shkolnik, M McConkey, AE Lin, M Słabicki, JP Kemp, ... Journal of Experimental Medicine 218 (12), e20211872, 2021 | 94 | 2021 |
| TET2-mutant clonal hematopoiesis and risk of gout M Agrawal, A Niroula, P Cunin, M McConkey, V Shkolnik, PG Kim, ... Blood, The Journal of the American Society of Hematology 140 (10), 1094-1103, 2022 | 76 | 2022 |
| Clonal haematopoiesis and risk of chronic liver disease WJ Wong, C Emdin, AG Bick, SM Zekavat, A Niroula, JP Pirruccello, ... Nature 616 (7958), 747-754, 2023 | 72 | 2023 |
| PON-Sol: prediction of effects of amino acid substitutions on protein solubility Y Yang, A Niroula, B Shen, M Vihinen Bioinformatics 32 (13), 2032-2034, 2016 | 59 | 2016 |
| PON-tstab: protein variant stability predictor. Importance of training data quality Y Yang, S Urolagin, A Niroula, X Ding, B Shen, M Vihinen International journal of molecular sciences 19 (4), 1009, 2018 | 58 | 2018 |
| A practical approach to curate clonal hematopoiesis of indeterminate potential in human genetic data sets C Vlasschaert, T Mack, JB Heimlich, A Niroula, MM Uddin, J Weinstock, ... Blood, The Journal of the American Society of Hematology 141 (18), 2214-2223, 2023 | 57 | 2023 |
| Association of diet quality with prevalence of clonal hematopoiesis and adverse cardiovascular events R Bhattacharya, SM Zekavat, MM Uddin, J Pirruccello, A Niroula, ... JAMA cardiology 6 (9), 1069-1077, 2021 | 53 | 2021 |
| TP53-mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease SM Zekavat, V Viana-Huete, N Matesanz, SD Jorshery, MA Zuriaga, ... Nature cardiovascular research 2 (2), 144-158, 2023 | 49* | 2023 |
| Working toward precision medicine: Predicting phenotypes from exomes in the Critical Assessment of Genome Interpretation (CAGI) challenges R Daneshjou, Y Wang, Y Bromberg, S Bovo, PL Martelli, G Babbi, ... Human mutation 38 (9), 1182-1192, 2017 | 49 | 2017 |
| PON-mt-tRNA: a multifactorial probability-based method for classification of mitochondrial tRNA variations A Niroula, M Vihinen Nucleic acids research 44 (5), 2020-2027, 2016 | 45 | 2016 |
